Plains GP Holdings, L.P. PAGP Gain (Loss) on Sale of Assets and Asset Impairment Charges
Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Plains GP Holdings, L.P. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.
The official record: Plains GP Holdings, L.P.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges?
- Plains GP Holdings, L.P. (PAGP) reported gain (loss) on sale of assets and asset impairment charges of $53M in Q1 2026.
- How has Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges increased by 307.7% year-over-year, from $13M to $53M.
- What is the long-term trend for Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges?
- Over 3 years (2021 to 2024), Plains GP Holdings, L.P.'s gain (loss) on sale of assets and asset impairment charges has grown at a -35.3% compound annual growth rate (CAGR), from -$592M to -$160M.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- This metric represents the net impact of gains or losses recognized from the disposal of property, plant, and equipment, alongside any non-cash charges related to the impairment of asset carrying values. It reflects management's success in optimizing the asset portfolio and the potential need for write-downs due to changes in market conditions or asset utility. Investors use this to assess the volatility of non-operating activities and the long-term recoverability of capital investments.